XML 37 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (USD $)
Total
USD ($)
All Other
USD ($)
In-Q-Tel
USD ($)
Related Party
USD ($)
Class A Common Amount
USD ($)
Class A Common Amount
All Other
USD ($)
Class A Common Amount
In-Q-Tel
USD ($)
Class A Common Amount
Related Party
Class B Common Amount
Additional Paid-in Capital
USD ($)
Additional Paid-in Capital
All Other
USD ($)
Additional Paid-in Capital
In-Q-Tel
USD ($)
Additional Paid-in Capital
Related Party
USD ($)
Accumulated Deficit
USD ($)
Beginning Balance at Apr. 01, 2010 $ 14,357,000       $ 24,000         $ 50,164,000       $ (35,831,000)
Beginning Balance (in shares) at Apr. 01, 2010         24,463,978       31,691          
Exercise of stock options (in shares)         194,141                  
Exercise of stock options 105,000                 105,000        
Reclassification of warrant fair value - PIPE 32,000                 32,000        
Reclassification of Class B Common Stock to Class A Common Stock         31,691       (31,691)          
Conversion of accrued interest on MEDC/MSF loans to common stock (in shares)         1,041,363                  
Conversion of accrued interest on MEDC/MSF loans to common stock 561,000       1,000         560,000        
Issuance of restricted shares         238,844                  
Issuance of restricted shares 1,000       1,000                  
Stock based compensation 225,000                 225,000        
Exercise of warrants (in shares)         135,598                  
Exercise of warrants 243,000                 243,000        
Issuance stock (in shares)           4,308,108 198,524 66,799            
Issuance stock   6,289,000 200,000 78,000   4,000 1,000       6,285,000 199,000 78,000  
Net loss and comprehensive loss (1,882,000)                         (1,882,000)
Ending Balance at Mar. 31, 2011 20,209,000       31,000         57,891,000       (37,713,000)
Ending Balance (in shares) at Mar. 31, 2011         30,679,046                  
Exercise of stock options (in shares)         80,949                  
Exercise of stock options 23,000                 23,000        
Issuance of restricted shares         399,436                  
Stock based compensation 532,000                 532,000        
Net loss and comprehensive loss (2,112,000)                         (2,112,000)
Ending Balance at Mar. 31, 2012 $ 18,652,000       $ 31,000         $ 58,446,000       $ (39,825,000)
Ending Balance (in shares) at Mar. 31, 2012         31,159,431